Skip to main content
OpenTrials

Clinical trial condition

Dyssomnias

Explore clinical trials studying Dyssomnias. Study availability and eligibility vary by location and protocol.

4,868 public trials 723 recruiting studies
Refine in advanced search Browse all conditions

Dyssomnias trial results

Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

NCT07369011

Conditions
Apnea, Body Weight, Dyssomnias, +14 more
Locations
  • Cullman Clinical Trials Cullman, Alabama, United States
  • Ark Clinical Research Long Beach, California, United States
  • Collaborative Neuroscience Research, LLC Los Alamitos, California, United States
  • Artemis Institute for Clinical Research Riverside, California, United States
View all 115 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

NCT07502443

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +7 more
Locations
  • Alkermes Investigational Site Cullman, Alabama, United States
  • Alkermes Investigational Site Los Angeles, California, United States
  • Alkermes Investigational Site Boulder, Colorado, United States
  • Alkermes Investigational Site Brandon, Florida, United States
View all 38 locations
View Trial Details
Recruiting

Endotype DIrected Treatment for OSA in Down Syndrome

NCT07280468

Conditions
Abnormalities, Multiple, Apnea, Chromosome Disorders, +16 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • University of Miami Miami, Florida, United States
  • Advocate Medical Group Adult Down Syndrome Center Park Ridge, Illinois, United States
View Trial Details
Recruiting

Neurocognition in Congenital Central Hypoventilation Syndrome (CCHS)

NCT03568669

Conditions
Apnea, CCHS, CCHS With Hirschsprung Disease, +13 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Seattle Children's Hospital Seattle, Washington, United States
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

NCT07455383

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +10 more
Locations
  • Alkermes Investigational Site Cullman, Alabama, United States
  • Alkermes Investigational Site Los Angeles, California, United States
  • Alkermes Investigational Site Boulder, Colorado, United States
  • Alkermes Investigational Site Brandon, Florida, United States
View all 42 locations
View Trial Details

Related conditions